[MO-86] Results of CFA intervention at our institute
【Objectives】Generally, surgical treatment including endoathelectomy is the first choice for treatment of CFA. A high restenosis rate has been reported for POBA, although there are acceptable results of stent, access site problems also exist. However, there are cases in which endovascular treatment is effective in daily clinical practice. Now we can avail some good scoring balloon, high pressure balloon and CROSSER. We also experience cases in which relatively good results can be obtained by combining them. The aim of this study is to investigate the efficacy of EVT for CFA.
【Method】We investigated 32 patients, 46 cases of EVT for CFA retrospectively from Jan,2016 to April 2018.
【Results】 Mean age was about 73. CKD was 76%, ESRD was 35%. CAD was 76% and three vessel CAD was 32%. CLI was 71.7%. CTO was about 50%. All cases were succeeded. All cases were performed only balloon angioplasty. Complication occurred 8.7% including 3 access site bleeding. 30-days mortality rate was 0%. 30-days major amputation 1-year TLR rate was 34%. 1-year secondary patency was 100%.
【Conclusion】 There were few complications. 30-days mortality and amputation free rate were acceptable. 1-year TLR rate was relatively high but secondary patency was acceptable even though only conventional PTA. From our study we think EVT for CFA is acceptable. Here, we report our data about CFA intervention in our institute and the representative case with severe calcified nodule that we combined CROSSER, scoring balloon and high-pressure balloon.
【Method】We investigated 32 patients, 46 cases of EVT for CFA retrospectively from Jan,2016 to April 2018.
【Results】 Mean age was about 73. CKD was 76%, ESRD was 35%. CAD was 76% and three vessel CAD was 32%. CLI was 71.7%. CTO was about 50%. All cases were succeeded. All cases were performed only balloon angioplasty. Complication occurred 8.7% including 3 access site bleeding. 30-days mortality rate was 0%. 30-days major amputation 1-year TLR rate was 34%. 1-year secondary patency was 100%.
【Conclusion】 There were few complications. 30-days mortality and amputation free rate were acceptable. 1-year TLR rate was relatively high but secondary patency was acceptable even though only conventional PTA. From our study we think EVT for CFA is acceptable. Here, we report our data about CFA intervention in our institute and the representative case with severe calcified nodule that we combined CROSSER, scoring balloon and high-pressure balloon.